組織工学心臓弁市場 - 2031年の成長予測、統計および事実

  • Report Code : TIPRE00010725
  • Category : Life Sciences
  • No. of Pages : 150
今すぐ購入

組織工学心臓弁市場は、2024年から2031年にかけて8.5%のCAGRを記録し、市場規模は2024年のXX百万米ドルから2031年にはXX百万米ドルに拡大すると予想されています。

レポートはタイプ別(経カテーテル心臓弁、組織心臓弁、機械心臓弁)に分割されています。レポートはさらにアプリケーション別(心臓手術、心血管疾患、その他)に分割されています。グローバル分析は、地域レベルと主要国別にさらに細分化されています。レポートは、上記の分析とセグメントに対して米ドルでの価値を提供します。

報告書の目的

The Insight Partners による組織工学心臓弁市場レポートは、現在の状況と将来の成長、主な推進要因、課題、機会を説明することを目的としています。これにより、次のようなさまざまなビジネス関係者に洞察が提供されます。

  • テクノロジープロバイダー/メーカー: 進化する市場の動向を理解し、潜在的な成長機会を把握することで、情報に基づいた戦略的意思決定が可能になります。
  • 投資家: 市場の成長率、市場の財務予測、バリュー チェーン全体に存在する機会に関する包括的な傾向分析を実施します。
  • 規制機関: 市場の濫用を最小限に抑え、投資家の信用と信頼を維持し、市場の完全性と安定性を維持することを目的として、市場における政策と警察活動を規制します。

 

組織工学心臓弁市場のセグメンテーション

 

種類

  • 経カテーテル心臓弁
  • 組織心臓弁
  • 人工心臓弁

アプリケーション

  • 心臓手術
  • 心血管疾患
  • その他

 

要件に合わせてレポートをカスタマイズする

このレポートの一部、国レベルの分析、Excelデータパックなど、あらゆるレポートを無料でカスタマイズできます。また、スタートアップや大学向けのお得なオファーや割引もご利用いただけます。

組織工学心臓弁市場:戦略的洞察

Tissue Engineered Heart Valve Market
  • このレポートの主要な市場動向を入手してください。
    この無料サンプルには、市場動向から見積もりや予測に至るまでのデータ分析が含まれます。

 

組織工学心臓弁市場の成長要因

  • 心血管疾患の増加: 世代が進むにつれて、心血管系に影響を及ぼす疾患、特に弁膜症の罹患率が人口内で増加しています。その結果、組織工学による心臓弁などの高度な治療法の必要性が高まっています。このような弁は、より長持ちし、拒絶反応の傾向が低く、患者の全体的な転帰が向上することが期待されるため、心臓弁置換術の市場が拡大します。
  • Technological Evolution in Regenerative Medicine: Advancements in the field of regenerative medicine and stem cell technology have catalyzed the invention of tissue engineered heart valves. This technology makes it possible to design artificial valves, which replicate the natural tissue properties to the optimum degree, improving the biocompatibility, lowering the risk of immunological response, and enhancing the functioning of the valve which results in increasing of the market.
  • Preference for Procedures That are Less Invasive: Synthetic heart valves are being more frequently implanted during less invasive procedures, for example, transcatheter valve-in-valve procedures, owing to their biocompatibility and ability to minimize adverse events such as thromboembolic phenomena or infections. The encouraging trend toward tissue-engineered heart valves in patients vascular intervention procedures is correlated with the less invasive approach.

Tissue Engineered Heart Valve Market Future Trends

  • Bioprinting and 3D Fabrication: Bioprinting is a relatively new technique in the engineering of tissue-based heart valves that facilitates accurate and patient-oriented custom-made valves. Living cells along with extracellular matrix materials can be printed out, allowing producers to create customized heart valves with better tissue integration, working efficiency, and longer service time.
  • Integration of Stem Cell Technologies: Stem cells have earned acclaim as critical components in producing tissue-engineered heart valves as a development process. They enable the repair of damaged heart valve tissues, giving rise to the development of replacement valves that are engineered to last longer and to be more biocompatible in individual patients. This is anticipated to transform heart valve treatment within the next few years.
  • Bioengineered Valves with Reduced Thrombogenicity: Attention of the manufacturers is also directed towards the creation of tissue-engineered heart valves that have lower thrombi-inducing properties (ability to induce clotting) to eliminate the need for anticoagulant drugs. Such trends would be fueled by the need for enhanced patient comfort and concerns on improved results on the use of tissue-engineered valves as opposed to standard prostheses.

Tissue Engineered Heart Valve Market Opportunities

  • Collaboration With Biotechnology and Educational Institutions: Collaboration of manufacturers with biobased businesses or academic institutions located beyond its conventional boundaries in order to obtain new ideas relating to development and production of stem cells, biomaterials or any regenerative medicine devices. Building these Partnerships can encourage the development of certain technologies even turning the concept into a commercialized product - a tissue-engineered heart valve for example, which does not only facilitate the development but also brings in new technologies that are competitive in the markets.
  • Targeting the Younger Demographic:There are applications for tissue engineered heart valves in younger patients but presents a clinical challenge because often mechanical or bioprosthetic valves will be replaced several times in a patient’s lifetime. Tissue engineered heart valves allows the patient to grow enabling better integration with the heart structures hence a more long-lasting solution as there is less frequent hospital visits to replace an implant.
  • Increasing Utilization in Transcatheter Valve Replacement: There is ample scope for developing tissue-engineered heart valves, especially in transcatheter aortic valve replacement. With the trend leaning heavily toward valve replacement without the need for a surgical incision, firms could focus on the tissue-engineered valves as the best possible option in TAVR due to their satisfactory performance and lessened associated complications surrounding the traditional prosthetic valves.

 

Tissue Engineered Heart Valve Market Regional Insights

The regional trends and factors influencing the Tissue Engineered Heart Valve Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Tissue Engineered Heart Valve Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

Tissue Engineered Heart Valve Market
  • Get the Regional Specific Data for Tissue Engineered Heart Valve Market

Tissue Engineered Heart Valve Market Report Scope

Report AttributeDetails
Market size in 2024US$ XX million
Market Size by 2031US$ XX Million
Global CAGR (2025 - 2031)8.5%
Historical Data2021-2023
Forecast period2025-2031
Segments CoveredBy Types
  • Transcatheter Heart Valves
  • Tissue Heart Valves
  • Mechanical Heart Valves
By Applications
  • Heart Surgery
  • Cardiovascular Disease
  • Others
Regions and Countries CoveredNorth America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Boston Scientific
  • Colibri Heart Valve
  • CryoLife, Inc.
  • Edwards Lifesciences Corporation
  • Lepu Medical Technology
  • LivaNova PLC
  • Medtronic Inc.
  • St. Jude Medical
  • Symetis SA

 

Tissue Engineered Heart Valve Market Players Density: Understanding Its Impact on Business Dynamics

The Tissue Engineered Heart Valve Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

市場プレーヤー密度とは、特定の市場または業界内で活動している企業または会社の分布を指します。これは、特定の市場スペースに、その規模または総市場価値と比較して、どれだけの競合相手 (市場プレーヤー) が存在するかを示します。

組織工学心臓弁市場で事業を展開している主要企業は次のとおりです。

  1. ボストン・サイエンティフィック
  2. コリブリ心臓弁
  3. クライオライフ株式会社
  4. エドワーズライフサイエンス株式会社
  5. レプメディカルテクノロジー

免責事項上記の企業は、特定の順序でランク付けされていません。


Tissue Engineered Heart Valve Market

 

  • 組織工学心臓弁市場のトップキープレーヤーの概要を入手

 

 

主なセールスポイント

 

  • 包括的なカバレッジ: レポートでは、組織工学心臓弁市場の製品、サービス、タイプ、エンドユーザーの分析を包括的にカバーし、全体的な展望を提供します。
  • 専門家による分析: レポートは、業界の専門家とアナリストの深い理解に基づいてまとめられています。
  • 最新情報: このレポートは、最新の情報とデータの傾向を網羅しているため、ビジネスの関連性を保証します。
  • カスタマイズ オプション: このレポートは、特定のクライアント要件に対応し、ビジネス戦略に適切に適合するようにカスタマイズできます。

したがって、組織工学心臓弁市場に関する調査レポートは、業界のシナリオと成長の見通しを解読し理解する道の先導役となることができます。いくつかの正当な懸念があるかもしれませんが、このレポートの全体的な利点は欠点を上回る傾向があります。

  • 過去2年間の分析、基準年、CAGRによる予測(7年間)
  • PEST分析とSWOT分析
  • 市場規模価値/数量 - 世界、地域、国
  • 業界と競争環境
  • Excel データセット
tissue-engineered-heart-valve-market-report-deliverables-img1
tissue-engineered-heart-valve-market-report-deliverables-img2
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

よくある質問


Which type segment dominates the tissue engineered heart valve market?

Based on type, the market is segmented as transcatheter heart valves, tissue heart valves, and mechanical heart valves. The pneumatic surgical suction pumps segment is expected to hold the largest tissue engineered heart valve market share in 2023.

What are the market players operating in the tissue engineered heart valve market?

Boston Scientific, Colibri Heart Valve, CryoLife Inc, Edwards Lifesciences Corporation, Lepu Medical Technology, LivaNova PLC, Medtronic Inc, St Jude Medical, Symetis SA
are some of the key players influencing the tissue engineered heart valve market.

What is the expected CAGR of the market?

The market is expected to grow at a CAGR of 8.5% during the forecast period

What are the driving factors impacting the tissue engineered heart valve market?

The major factors driving the tissue engineered heart valve market are:

1. Rising Number of Cardiovascular Diseases
2. Technological Evolution in Regenerative Medicine
3. Preference for Procedures That are Less Invasive

Which region is expected to hold the largest share in the global tissue engineered heart valve market?

North America is expected to hold the largest share in the global liposuction devices market.

Which end user segment dominates the tissue engineered heart valve market?

On the basis of end-user market is further broken down into hospitals and clinics, ambulatory surgical centers, others. The hospitals and clinics segment is expected to hold the largest tissue engineered heart valve market share in 2023.

Trends and growth analysis reports related to Life Sciences : READ MORE..   
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

The List of Companies

1. Boston Scientific
2. Colibri Heart Valve
3. CryoLife, Inc.
4. Edwards Lifesciences Corporation
5. Lepu Medical Technology
6. LivaNova PLC
7. Medtronic Inc.
8. St. Jude Medical
9. Symetis SA
10. TTK Healthcare Limited
tissue-engineered-heart-valve-market-cagr

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.